全文获取类型
收费全文 | 16204篇 |
免费 | 1776篇 |
国内免费 | 396篇 |
专业分类
耳鼻咽喉 | 138篇 |
儿科学 | 278篇 |
妇产科学 | 193篇 |
基础医学 | 1959篇 |
口腔科学 | 366篇 |
临床医学 | 1177篇 |
内科学 | 1060篇 |
皮肤病学 | 2087篇 |
神经病学 | 342篇 |
特种医学 | 512篇 |
外国民族医学 | 13篇 |
外科学 | 1364篇 |
综合类 | 1987篇 |
现状与发展 | 3篇 |
预防医学 | 409篇 |
眼科学 | 705篇 |
药学 | 841篇 |
13篇 | |
中国医学 | 395篇 |
肿瘤学 | 4534篇 |
出版年
2024年 | 29篇 |
2023年 | 270篇 |
2022年 | 319篇 |
2021年 | 631篇 |
2020年 | 648篇 |
2019年 | 613篇 |
2018年 | 560篇 |
2017年 | 610篇 |
2016年 | 653篇 |
2015年 | 747篇 |
2014年 | 934篇 |
2013年 | 1118篇 |
2012年 | 796篇 |
2011年 | 871篇 |
2010年 | 685篇 |
2009年 | 652篇 |
2008年 | 691篇 |
2007年 | 701篇 |
2006年 | 664篇 |
2005年 | 660篇 |
2004年 | 573篇 |
2003年 | 516篇 |
2002年 | 458篇 |
2001年 | 420篇 |
2000年 | 355篇 |
1999年 | 325篇 |
1998年 | 293篇 |
1997年 | 276篇 |
1996年 | 256篇 |
1995年 | 224篇 |
1994年 | 200篇 |
1993年 | 183篇 |
1992年 | 164篇 |
1991年 | 185篇 |
1990年 | 137篇 |
1989年 | 125篇 |
1988年 | 101篇 |
1987年 | 96篇 |
1986年 | 79篇 |
1985年 | 89篇 |
1984年 | 87篇 |
1983年 | 67篇 |
1982年 | 53篇 |
1981年 | 59篇 |
1980年 | 63篇 |
1979年 | 31篇 |
1978年 | 28篇 |
1977年 | 23篇 |
1976年 | 19篇 |
1972年 | 24篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
21.
22.
苏影 《中国继续医学教育》2021,(1)
目的探讨眼睑恶性肿瘤切除术中应用Z形皮瓣及推进皮瓣I期修复眼睑缺损的临床效果。方法将50例眼睑恶性肿瘤切除术患者按不同缝合方法分为两组,即对照组25例,术中直接缝合;观察组25例,术中行Z形皮瓣及推进皮瓣I期修复;比较两组眼睑修复效果。结果观察组术后皮瓣成活率96.0%、切口Ⅰ期愈合率100%、修复满意率92.0%,均高于对照组的72.0%、68.0%、56.0%,差异有统计学意义(P<0.05)。观察组术后并发症发生率低于对照组,但差异无统计学意义(P>0.05)。结论眼睑恶性肿瘤切除术中眼睑缺损修复时,采用Z形皮瓣及推进皮瓣,眼睑修复良好,患者修复满意率高,值得推广应用。 相似文献
23.
扩散加权成像在鉴别颅内环形强化病灶的价值 总被引:1,自引:1,他引:0
目的讨论扩散加权成像(DWI)和表观扩散系数(ADC)在鉴别颅内环形强化病灶性质的价值。资料与方法应用1.5TMR对16例胶质瘤、6例转移瘤、4例脑脓肿进行常规MR及DWI成像和ADC测量,分析其影像学表现。结果4例脑脓肿在DWI上呈高信号,16例胶质瘤和6例转移瘤呈低信号,脓肿腔平均ADC值为0.44×10-3cm2/s,脑肿瘤坏死囊变区平均ADC值为1.82×10-3cm2/s(P<0.01)。结论DWI和ADC值可以用来鉴别脑脓肿及坏死囊变的肿瘤病灶。 相似文献
24.
S Aquilina† M Dalmas‡ N Calleja§ P Gatt† L Scerri† 《Journal of the European Academy of Dermatology and Venereology》2006,20(8):958-963
BACKGROUND: The incidence of malignant melanoma of the skin has risen in every part of the world where reliable cancer registration data are found. OBJECTIVE: Our study aims to describe the changing incidence of and survival from invasive cutaneous malignant melanoma in Malta, by analysing the data from the 211 cases that were registered at the Malta National Cancer Registry between 1993 and 2002. RESULTS: The age standardized incidence rates for invasive cutaneous malignant melanoma rose from 3.7 per 100,000 population per year for males and 5.1 for females in the first 5-year period, to 8.0 per 100,000 population per year for males and 5.9 for females in the second 5-year period. In both sexes, numbers of thin (< or = 1.0 mm) invasive melanomas increased significantly between 1993 and 2002; males also registered a significant increase in intermediate-thickness (1.01-4.0 mm) melanomas. The increase in numbers of thin and intermediate-thickness melanomas between the two 5-year periods was greatest in patients aged 60 years and over. The overall absolute 5-year survival rate for the first period was 74% and for the second period 92%. CONCLUSION: Numbers of reported cases of invasive cutaneous malignant melanoma in Malta have more than doubled during the 10-year study period. This is mostly due to a marked rise in the diagnosis of thin melanomas in both sexes, occurring mainly in patients aged 60 years and over. As thin melanomas are of low metastasizing potential, this has resulted in an increase in survival between the two 5-year study periods. 相似文献
25.
Primary malignant melanoma of the bladder 总被引:1,自引:0,他引:1
MAURO PACELLA FABRIZIO GALLO CHRISTIAN GASTALDI CARLO AMBRUOSI GIORGIO CARMIGNANI 《International journal of urology》2006,13(5):635-637
Primary malignant melanomma of bladder is extremely rare: 18 cases are reported to date. An 82 year-old man underwent trans-urethral resection of bladder for a bleeding tumor of the posterior wall. Histological diagnosis was melanoma of the bladder. There was no history of previous or regressed cutaneous malignant melanoma. Margins of the bladder lesion contained atypical melanocytes similar to those commonly seen in the periphery of primary mucous membrane lesions. Clinical studies and radiological examinations were negative for other primary site of melanoma. The patient had a bladder recurrence that was consistent with primary tumor and died of widespread disease 9 months after diagnosis. 相似文献
26.
本文报道了我院收治的卵巢恶性畸胎瘤31例,随访中2例失访,随访率为93.53%。并讨论了卵巢恶性畸瘤的治疗方式为手术加联合化疗,对年轻的I期患者可行患侧单侧附件切除术,术后化疗极为重要。化疗方法采用VAC或PVB方案联合化疗,本文还 影响预后的重要因素为临床分期期和病理学特点. 相似文献
27.
分析原发性腹膜后恶性肿瘤12例。83%以腹块和腹痛为主要症状,体征中腹块占91.5%,以恶性淋巴瘤居首位占61%。全组完全切除率为58%,行脏器联合切除占25%。完全切除加放疗、化疗3年存活率为28.5%,部分切除及活检未给其它治疗者5例预后差,均1年内死亡,差别显著。 相似文献
28.
Uptake of Adriamycin in tumour and surrounding brain tissue in patients with malignant gliomas 总被引:1,自引:0,他引:1
H. von Holst E. Knochenhauer H. Blomgren V. P. Collins L. Ehn M. Lindquist G. Norén C. Peterson 《Acta neurochirurgica》1990,104(1-2):13-16
Summary Eight patients with malignant gliomas verified on CT scan, received an intravenous injection of 50 mg of Adriamycin R, 24 hours prior to surgical removal of the tumour. Peroperatively, both tumour and surrounding tissue specimens were obtained for determination of the tissue concentrations of Adriamycin and its reduced metabolite Adriamycinol. It was found that Adriamycin could be detected in tumour tissue from all patients. The concentration varied between 0,9 and 4,6 nmol/g tissue. In contrast, Adriamycin could only be detected in surrounding brain tissue from one patient.In anin vitro study a human malignant glioma cell line (U-251 MG) was exposed to various concentrations of Adriamycin for 24 hours. It was found that an intracellular drug concentration above 30 nmol/g cells caused a concentration dependent inhibition of cell growth. Thus, it is likely that the poor effect of Adriamycin on patients with malignant gliomas is due to an ineffective drug accumulation in the tumour tissue. 相似文献
29.
30.
Ch. Lenzen N. Roewer F. Wappler A. Köchling M. Steinfath J. Sgholz J. Schulte am Esch 《Acta anaesthesiologica Scandinavica》1995,39(3):343-346
Dantrolene seems to be the causal therapy in malignant hyperthermia (MH) crisis but the complex mechanisms of MH and dantrolene therapy are still not fully understood. The influence of dantrolene on ryanodine-induced contractures has been reported in animal studies only. In the present study 20 patients from] 7 families were tested for MH using the protocol of the European Malignant Hyperthermia Group. In addition ryanodine-induced contractures were evaluated following bolus application of 10.0 μmol · 1-1 ryanodine. After pretreatment with 1 μimol · 1-1 dantrolene ryanodine-provoked contractures developed significantly later in MHS (15.8±1.8 min) and MHN (46.0±4.2 min) muscle specimens than after ryanodine alone (MHS 4.8±0.7 min), (MHN 13.7±0.9 min). They were no longer observed in either group after pretreatment with 5 μimol · 1-1 dantrolene. We conclude that dantrolene is able to attenuate ryanodine-induced contractures dose-dependendy, and therefore it is speculated that dantrolene could specifically act at the ryanodine receptor binding site. 相似文献